Average Co-Inventor Count = 4.36
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (56 from 2,405 patents)
2. Merck Sharpe & Dohme Corp. (6 from 35 patents)
3. Dohme Ltd. (1 from 1 patent)
4. Merck Sharp (1 from 1 patent)
63 patents:
1. 6613765 - Use of NK-1 receptor antagonists for treating major depressive disorders
2. 6271230 - Use of NK-1 receptor antagonists for treating cognitive disorders
3. 6114315 - Use of NK-1 receptor antagonists for treating major depressive disorders
4. 6100256 - Use of NK-1 receptors antagonists for treating schizophrenic disorders
5. 6096766 - 3-benzylaminopiperidines as tachykinin receptor antagonists
6. 6096729 - Use of NK-1 receptor antagonists for treating amnestic disorders
7. 6087348 - Use of NK-1 receptor antagonists for treating stress disorders
8. 6071927 - Spiro-piperidine derivatives and their use as therapeutic agents
9. 6060469 - Spiro-piperidine derivatives and their use as tachykinin antagonists
10. 5985896 - Piperidine and morpholine derivatives and their use as therapeutic agents
11. 5981529 - Substituted indolylpropyl-piperazine derivatives as 5-HT.sub.1D .alpha.
12. 5977104 - Use of NK-1 receptor antagonists for treating bipolar disorders
13. 5952315 - Use of NK-1 receptor antagonists for treating bipolar disorders
14. 5929054 - Use of NK-1 receptor antagonists for treating sexual dysfunctions
15. 5925627 - Use of NK-1 receptor antagonists for treating movement disorders